コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ar invasion (LVI), and 8% lobular neoplasia (lobular carcinoma in situ).
2 ts (one atypical lobular hyperplasia and one lobular carcinoma in situ).
3 perplasia, atypical lobular hyperplasia, and lobular carcinoma in situ.
4 gn, 47 showed atypical histology, and 4 were lobular carcinoma in situ.
5 % of preinvasive lesions, such as ductal and lobular carcinoma in situ.
6 eight atypical lobular hyperplasia, and one lobular carcinoma in situ.
7 equivalent measure) or women diagnosed with lobular carcinoma in situ.
8 f breast cancer,ductal carcinoma in situ, or lobular carcinoma in situ.
9 ith proliferative breast lesions (ductal and lobular carcinoma in situ and atypical ductal hyperplasi
10 diotherapy, ductal carcinoma with concurrent lobular carcinoma in situ, and DCIS in elderly people an
12 h-risk lesions (atypical ductal hyperplasia, lobular carcinoma in situ, atypical lobular hyperplasia)
13 two, atypical lobular hyperplasia and focal lobular carcinoma in situ in one, and ductal hyperplasia
14 nly rare cells of the noninvasive component (lobular carcinoma in situ) in the same tissue sections s
15 ++ were classified as being within ductal or lobular carcinoma in situ, invasive carcinoma, carcinoma
16 biased by small sample size, by interpreting lobular carcinoma in situ (LCIS) as a positive result, b
17 east cancer risk conferred by a diagnosis of lobular carcinoma in situ (LCIS) is poorly understood.
18 tu (DCIS) and 282 women with a first primary lobular carcinoma in situ (LCIS) were followed for contr
19 red the association between risk factors and lobular carcinoma in situ (LCIS; n = 186) with that of r
20 ive breast cancer (IBC) after a diagnosis of lobular carcinoma-in-situ (LCIS) by using Surveillance,
21 in the atypical lobular hyperplasia (n = 2), lobular carcinoma in situ (n = 5), or radial scar (n = 3
23 ical type (p=0.03), with a relative risk for lobular carcinoma in situ of 2.82 (1.72-4.63) and 1.56 (
25 l hyperplasia, atypical lobular hyperplasia, lobular carcinoma in situ, or radial scar) was identifie
26 pical hyperplasia, Gail risk greater than 5, lobular carcinoma-in-situ, or two or more first-degree r
27 or atypical ductal or lobular hyperplasia or lobular carcinoma in situ; or ductal carcinoma in situ w
28 ecent year of diagnosis, and the presence of lobular carcinoma in situ were significantly associated
29 ost in the vast majority (13/17) of cases of lobular carcinoma in situ, which is defined by cellular
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。